Class information for:
Level 1: BAZEDOXIFENE//RALOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
10428 1065 41.8 81%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
159 3       MENOPAUSE//ISOFLAVONES//TAMOXIFEN 61134
329 2             TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS 18133
10428 1                   BAZEDOXIFENE//RALOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX 1065

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BAZEDOXIFENE authKW 1191618 6% 62% 67
2 RALOXIFENE authKW 1109262 18% 20% 189
3 TISSUE SELECTIVE ESTROGEN COMPLEX authKW 569440 2% 83% 24
4 SELECTIVE ESTROGEN RECEPTOR MODULATOR authKW 483957 8% 20% 83
5 LASOFOXIFENE authKW 409888 2% 62% 23
6 TSEC authKW 379454 1% 88% 15
7 SERM authKW 241248 5% 17% 50
8 CONJUGATED ESTROGENS authKW 231686 3% 29% 28
9 BREAST CANCER PREVENTION authKW 225324 2% 30% 26
10 MIDLIFE HLTH address 224762 1% 56% 14

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 4605 35% 0% 370
2 Obstetrics & Gynecology 4194 19% 0% 207
3 Medicine, General & Internal 693 13% 0% 140
4 Endocrinology & Metabolism 679 11% 0% 115
5 Geriatrics & Gerontology 554 4% 0% 44
6 Pharmacology & Pharmacy 265 12% 0% 124
7 Women’s Studies 236 2% 0% 16
8 Reproductive Biology 197 3% 0% 32
9 Public, Environmental & Occupational Health 81 5% 0% 53
10 Primary Health Care 76 1% 0% 10

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MIDLIFE HLTH 224762 1% 56% 14
2 PREVENT OUTREACH PROGRAMS 57340 0% 100% 2
3 EARLY DETECT COMMUNITY ONCOL PROGRAM 51604 0% 60% 3
4 LYNN SAGE BREAST CANC PROGRAM 38222 0% 33% 4
5 CANC PREVENT GENET 34449 1% 9% 14
6 SURG ADJUVANT BREAST BOWEL PROJECT 30528 1% 15% 7
7 ANTHROPOL INVEST 28670 0% 100% 1
8 BAYLOR CANC 28670 0% 100% 1
9 BESINS INT 28670 0% 100% 1
10 BRANCH MED STAT BIOMETRY 28670 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY 28093 4% 2% 47
2 MATURITAS 7179 3% 1% 30
3 CLIMACTERIC 6886 2% 2% 16
4 JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 4490 2% 1% 20
5 BREAST CANCER RESEARCH AND TREATMENT 4012 3% 0% 32
6 BREAST CANCER RESEARCH 2946 1% 1% 15
7 CANCER PREVENTION RESEARCH 2326 1% 1% 10
8 BREAST JOURNAL 2204 1% 1% 9
9 JOURNAL OF CLINICAL ONCOLOGY 1880 3% 0% 33
10 MEDSCAPE WOMENS HEALTH 1788 0% 3% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 BAZEDOXIFENE 1191618 6% 62% 67 Search BAZEDOXIFENE Search BAZEDOXIFENE
2 RALOXIFENE 1109262 18% 20% 189 Search RALOXIFENE Search RALOXIFENE
3 TISSUE SELECTIVE ESTROGEN COMPLEX 569440 2% 83% 24 Search TISSUE+SELECTIVE+ESTROGEN+COMPLEX Search TISSUE+SELECTIVE+ESTROGEN+COMPLEX
4 SELECTIVE ESTROGEN RECEPTOR MODULATOR 483957 8% 20% 83 Search SELECTIVE+ESTROGEN+RECEPTOR+MODULATOR Search SELECTIVE+ESTROGEN+RECEPTOR+MODULATOR
5 LASOFOXIFENE 409888 2% 62% 23 Search LASOFOXIFENE Search LASOFOXIFENE
6 TSEC 379454 1% 88% 15 Search TSEC Search TSEC
7 SERM 241248 5% 17% 50 Search SERM Search SERM
8 CONJUGATED ESTROGENS 231686 3% 29% 28 Search CONJUGATED+ESTROGENS Search CONJUGATED+ESTROGENS
9 BREAST CANCER PREVENTION 225324 2% 30% 26 Search BREAST+CANCER+PREVENTION Search BREAST+CANCER+PREVENTION
10 SERMS 187091 4% 17% 39 Search SERMS Search SERMS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 NELSON, HD , SMITH, B , GRIFFIN, JC , FU, RW , (2013) USE OF MEDICATIONS TO REDUCE RISK FOR PRIMARY BREAST CANCER: A SYSTEMATIC REVIEW FOR THE US PREVENTIVE SERVICES TASK FORCE.ANNALS OF INTERNAL MEDICINE. VOL. 158. ISSUE 8. P. 604 -+ 71 75% 45
2 KOMM, BS , MIRKIN, S , (2014) AN OVERVIEW OF CURRENT AND EMERGING SERMS.JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 143. ISSUE . P. 207 -222 62 52% 43
3 VISVANATHAN, K , HURLEY, P , BANTUG, E , BROWN, P , COL, NF , CUZICK, J , DAVIDSON, NE , DECENSI, A , FABIAN, C , FORD, L , ET AL (2013) USE OF PHARMACOLOGIC INTERVENTIONS FOR BREAST CANCER RISK REDUCTION: AMERICAN SOCIETY OF CLINICAL ONCOLOGY CLINICAL PRACTICE GUIDELINE.JOURNAL OF CLINICAL ONCOLOGY. VOL. 31. ISSUE 23. P. 2942-+ 41 73% 84
4 KOMM, BS , MIRKIN, S , JENKINS, SN , (2014) DEVELOPMENT OF CONJUGATED ESTROGENS/BAZEDOXIFENE, THE FIRST TISSUE SELECTIVE ESTROGEN COMPLEX (TSEC) FOR MANAGEMENT OF MENOPAUSAL HOT FLASHES AND POSTMENOPAUSAL BONE LOSS.STEROIDS. VOL. 90. ISSUE . P. 71 -81 49 68% 6
5 LI, FX , DOU, JL , WEI, LJ , LI, SX , LIU, JT , (2016) THE SELECTIVE ESTROGEN RECEPTOR MODULATORS IN BREAST CANCER PREVENTION.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 77. ISSUE 5. P. 895 -903 38 81% 1
6 MOYER, VA , (2013) MEDICATIONS FOR RISK REDUCTION OF PRIMARY BREAST CANCER IN WOMEN: U. S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION STATEMENT.ANNALS OF INTERNAL MEDICINE. VOL. 159. ISSUE 10. P. 698 -+ 35 81% 31
7 BAMBHROLIYA, A , CHAVEZ-MACGREGOR, M , BREWSTER, AM , (2015) BARRIERS TO THE USE OF BREAST CANCER RISK REDUCTION THERAPIES.JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. VOL. 13. ISSUE 7. P. 927 -935 36 77% 3
8 SHARIFI, M , LEWIECKI, EM , (2014) CONJUGATED ESTROGENS COMBINED WITH BAZEDOXIFENE: THE FIRST APPROVED TISSUE SELECTIVE ESTROGEN COMPLEX THERAPY.EXPERT REVIEW OF CLINICAL PHARMACOLOGY. VOL. 7. ISSUE 3. P. 281 -291 39 71% 6
9 ROETZHEIM, RG , LEE, JH , FULP, W , GOMEZ, EM , CLAYTON, E , TOLLIN, S , KHAKPOUR, N , LARONGA, C , LEE, MC , KILUK, JV , (2015) ACCEPTANCE AND ADHERENCE TO CHEMOPREVENTION AMONG WOMEN AT INCREASED RISK OF BREAST CANCER.BREAST. VOL. 24. ISSUE 1. P. 51 -56 28 88% 9
10 SMITH, CL , SANTEN, RJ , KOMM, B , MIRKIN, S , (2014) BREAST-RELATED EFFECTS OF SELECTIVE ESTROGEN RECEPTOR MODULATORS AND TISSUE-SELECTIVE ESTROGEN COMPLEXES.BREAST CANCER RESEARCH. VOL. 16. ISSUE 3. P. - 49 56% 1

Classes with closest relation at Level 1


Rank Class id link
1 6521 TAMOXIFEN//TOREMIFENE//ANTIESTROGEN
2 4960 AROMATASE INHIBITORS//AROMATASE INHIBITOR//ANASTROZOLE
3 4066 HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//WOMENS HEALTH INITIATIVE
4 11036 VAGINAL ATROPHY//VULVOVAGINAL ATROPHY//OSPEMIFENE
5 19527 ENDOXIFEN//TAMOXIFEN//N DESMETHYLTAMOXIFEN
6 12278 SERAM//MATH CHEM//RELATIVE BINDING AFFINITY
7 5771 ANTIESTROGEN//ANTIESTROGEN BINDING SITES//AEBS
8 7865 MAMMOGRAPHIC DENSITY//BREAST DENSITY//MAMMOGRAPHIC BREAST DENSITY
9 1788 BISPHOSPHONATES//ALENDRONATE//RISEDRONATE
10 471 BRCA2//BRCA1//HEREDITARY BREAST CANCER

Go to start page